Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sascha A Tuchman

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
High-risk multiple myeloma: does it still exist?Sascha A Tuchman, Sagar Lonial
Hematology/Oncology Clinics of North America|October 25, 2020
The Spectrum of Monoclonal Immunoglobulin-Associated DiseasesSascha A Tuchman, Jeffrey A Zonder
Oncotargets and Therapy|December 24, 2016
Non-secretory multiple myeloma: from biology to clinical managementMegan Murray Dupuis, Sascha A Tuchman
Clinics in Geriatric Medicine|November 29, 2015
Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older AdultsEmily J Guerard, Sascha A Tuchman
Blood|August 28, 2020
Thrombosis in the modern era of multiple myelomaSamuel M Rubinstein, Sascha A Tuchman
Hematological Oncology|June 16, 2015
Re: intrathecal vincristine as mentioned in 'overview of recent trends in diagnosis and management of leptomeningeal multiple myeloma' by Yellu et alLi-Wen Huang, Sascha A Tuchman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Multiple myeloma in the older adult: better prospects, more challengesTanya M Wildes, Ashley Rosko, Sascha A Tuchman
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2018
Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel TherapiesBita Fakhri, Mark A Fiala, Sascha A Tuchman, et al.
Journal of Geriatric Oncology|May 31, 2020
Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatmentHira Mian, Gregory R Pond, Sascha A Tuchman, et al.
JCO Clinical Cancer Informatics|December 15, 2018
Development of an Algorithm to Distinguish Smoldering Versus Symptomatic Multiple Myeloma in Claims-Based Data SetsMark A Fiala, James Dukeman, Sascha A Tuchman, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
High-risk multiple myeloma: does it still exist?Sascha A Tuchman, Sagar Lonial
Hematology/Oncology Clinics of North America|October 25, 2020
The Spectrum of Monoclonal Immunoglobulin-Associated DiseasesSascha A Tuchman, Jeffrey A Zonder
Oncotargets and Therapy|December 24, 2016
Non-secretory multiple myeloma: from biology to clinical managementMegan Murray Dupuis, Sascha A Tuchman
Clinics in Geriatric Medicine|November 29, 2015
Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma in Older AdultsEmily J Guerard, Sascha A Tuchman
Blood|August 28, 2020
Thrombosis in the modern era of multiple myelomaSamuel M Rubinstein, Sascha A Tuchman
Hematological Oncology|June 16, 2015
Re: intrathecal vincristine as mentioned in 'overview of recent trends in diagnosis and management of leptomeningeal multiple myeloma' by Yellu et alLi-Wen Huang, Sascha A Tuchman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Multiple myeloma in the older adult: better prospects, more challengesTanya M Wildes, Ashley Rosko, Sascha A Tuchman
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2018
Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel TherapiesBita Fakhri, Mark A Fiala, Sascha A Tuchman, et al.
Journal of Geriatric Oncology|May 31, 2020
Geriatric assessment and quality of life changes in older adults with newly diagnosed multiple myeloma undergoing treatmentHira Mian, Gregory R Pond, Sascha A Tuchman, et al.
JCO Clinical Cancer Informatics|December 15, 2018
Development of an Algorithm to Distinguish Smoldering Versus Symptomatic Multiple Myeloma in Claims-Based Data SetsMark A Fiala, James Dukeman, Sascha A Tuchman, et al.
Pageof 5